Home/Filings/4/0001104659-12-012638
4//SEC Filing

Day Wesley 4

Accession 0001104659-12-012638

CIK 0000881524other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 8:33 PM ET

Size

18.5 KB

Accession

0001104659-12-012638

Insider Transaction Report

Form 4
Period: 2012-02-23
Day Wesley
VP, Clinical Research
Transactions
  • Exercise/Conversion

    Common Stock

    2012-02-23$3.28/sh+9,958$32,66226,758 total
  • Exercise/Conversion

    Common Stock

    2012-02-23$4.25/sh+19,738$83,88736,538 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-02-2350,2620 total
    Exercise: $4.25Exp: 2017-01-29Common Stock (50,262 underlying)
  • Sale

    Common Stock

    2012-02-23$20.69/sh19,738$408,37916,800 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-02-2319,7380 total
    Exercise: $4.25Exp: 2017-01-29Common Stock (19,738 underlying)
  • Sale

    Common Stock

    2012-02-23$20.69/sh9,958$206,03116,800 total
  • Exercise/Conversion

    Common Stock

    2012-02-23$4.25/sh+50,262$213,61467,062 total
  • Sale

    Common Stock

    2012-02-23$20.69/sh50,262$1,039,92116,800 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-02-239,9580 total
    Exercise: $3.28Exp: 2016-05-09Common Stock (9,958 underlying)
Footnotes (2)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2011.
  • [F2]The option is fully vested and immediately exercisable.

Documents

1 file

Issuer

VIVUS INC

CIK 0000881524

Entity typeother

Related Parties

1
  • filerCIK 0001341526

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:33 PM ET
Size
18.5 KB